Versailles, France

Francois-Xaver Jarreau

This inventor holds 1 USPTO granted patent. Top assignee: Etablissements Nativelle, S.a.. Active years: 1982.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Francois-Xaver Jarreau

Introduction

Francois-Xaver Jarreau is a notable inventor based in Versailles, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of steroid derivatives. His work has implications for various therapeutic applications.

Latest Patents

Jarreau holds a patent for "Amino-14 steroid derivatives and process for preparation of the same." This invention relates to medicinally useful steroid derivatives, specifically amino-14 steroids that are substituted at the 17-position by a functional group. The patent outlines a process for preparing these amino-14 steroids from the corresponding hydroxy-14 steroids through the action of hydrazoic acid in the presence of boron trifluoride etherate, resulting in the formation of the azido-14 derivative which is subsequently reduced. He has 1 patent to his name.

Career Highlights

Francois-Xaver Jarreau has worked with Etablissements Nativelle, a company that focuses on innovative solutions in the pharmaceutical sector. His expertise in steroid chemistry has positioned him as a valuable asset in the field.

Collaborations

Jarreau has collaborated with Jean J Koenig, contributing to advancements in their shared research interests. Their partnership has fostered innovation and development in medicinal chemistry.

Conclusion

Francois-Xaver Jarreau's contributions to the field of medicinal chemistry through his patent on amino-14 steroid derivatives highlight his innovative spirit and dedication to advancing healthcare solutions. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…